22157.jpg
Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand
April 13, 2021 06:13 ET | Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021" report has been added to ResearchAndMarkets.com's offering. The main...
22157.jpg
Global Stem Cell Partnering Terms and Agreements Directory 2020: Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target & Technology Type
February 05, 2021 07:13 ET | Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Stem Cell Partnering Terms and Agreements 2010-2020" report has been added to ResearchAndMarkets.com's offering. The Global Stem Cell Partnering...
TMlogo.jpg
Q Therapeutics Announces Joint Venture With REPROCELL
April 23, 2018 05:00 ET | Q Therapeutics, Inc.
PARTNERSHIP WILL DEVELOP IPSC-DERIVED PRODUCTS TO TREAT CENTRAL NERVOUS SYSTEM DISEASES INVOLVING DEMYELINATION AND DEGENERATIONSALT LAKE CITY and YOKOHAMA, Japan, April 23, 2018 (GLOBE NEWSWIRE) --...
TMlogo.jpg
Q Therapeutics Announces Research Collaboration With REPROCELL
December 13, 2017 07:00 ET | Q Therapeutics, Inc.
SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury,...